Instead, this paper emphasizes recent insights into the involvement of transcriptional cofactors of the MYOCD family in cardiac dysfunction and to what extent experimental modulation of these factors' expression in vivo can correlate with cardiac disease outcome. The gene discussed is MYOCD; the disease is heart disorder.